Regeneus Ltd (ASX:RGS) Presentation for AusBiotech 2018
Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, is pleased to announce John Martin, CEO, will present at the AusBiotech 2018 Conference today.
Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, is pleased to announce John Martin, CEO, will present at the AusBiotech 2018 Conference today.
Nanollose Limited (ASX:NC6) is pleased to provide its Appendix 4C cash flow statement for the quarter ending 30 September 2018, together with the following operational update.
Rhinomed (ASX:RNO) (OTCMKTS:RHNMF) a leader in nasal delivery technology, today announced its 7th consecutive quarter on quarter of revenue growth. Positive trading conditions saw unaudited recognised revenues increase 30% over FY18 Q4 to $1.14m for FY19 Q1.
Anatara Lifesciences (ASX:ANR) is pleased to release its Appendix 4C for the quarter ending 30th September 2018. The Company's cash position at the end of the quarter stood at $7.1m.
Nanollose Limited (ASX:NC6) is pleased to provide more information around the successful creation of a test garment made from the Company's Nullarbor(TM) fibre. This marks the first time a piece of clothing has been made using our Tree-Free rayon fibre, and is a drastic departure from clothing made from traditional rayon fibre that comes from environmentally challenging wood pulp processing.
Anatara Lifesciences (ASX:ANR) is pleased to announce that the Australian Pesticides and Veterinary Medicines Authority has registered Detach(R) with the approved label, "To aid in the control of scour and has positive health benefits in weaned piglets from 3 weeks of age and help increase survivability of scouring pre-weaning piglets".
Nanollose Limited (ASX:NC6) reminds shareholders that its 2018 Annual General Meeting will be held at 1:00pm WST on Monday, 29 October 2018 at its registered office.